©The Author(s) 2019.
World J Gastrointest Oncol. Jan 15, 2019; 11(1): 48-58
Published online Jan 15, 2019. doi: 10.4251/wjgo.v11.i1.48
Published online Jan 15, 2019. doi: 10.4251/wjgo.v11.i1.48
Table 1 Classification of lymph node regression and residual tumor status
| Group | Description |
| A | True negative LNs with no evidence of a preoperative therapy effect |
| B | No residual metastasis but presence of regression change in LNs |
| C | Residual metastasis with regression change in LNs |
| D | Metastasis with minimal or no regression change in LNs |
- Citation: Zhu YL, Sun YK, Xue XM, Yue JY, Yang L, Xue LY. Unnecessity of lymph node regression evaluation for predicting gastric adenocarcinoma outcome after neoadjuvant chemotherapy. World J Gastrointest Oncol 2019; 11(1): 48-58
- URL: https://www.wjgnet.com/1948-5204/full/v11/i1/48.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i1.48